Deep Insight

Addionics is a London-based company, founded in 2017, that specializes in the design and development of next-generation rechargeable batteries, particularly for electric vehicles. The company utilizes an innovative 3D battery architecture to create batteries with improved energy density, reduced charging times, and enhanced safety. By redesigning the internal structure of batteries at a microscopic level, Addionics aims to minimize internal resistance and increase mechanical longevity, which significantly enhances performance across various battery chemistries. The company is focused on scaling its proprietary technology to revolutionize energy storage solutions and positively impact environmental sustainability, catering to the growing demand from battery manufacturers and automakers for advanced energy storage systems.

Magnus Metal Ltd. is a company based in Nes Ziona, Israel, specializing in the development and manufacturing of additive casting technology. This innovative approach combines traditional casting methods with digital processes, allowing for the high-volume production of large and complex load-bearing metal parts. Magnus Metal's services cater to various industries, including industrial tooling, powertrain and engine assemblies, chassis, and structural components for applications in robotics, heavy-duty machinery, vehicles, trucks, and trains. The company's technology enhances design flexibility and supports multi-alloy capabilities, resulting in homogeneous, predictable, and accurate products while reducing costs per part.

Greeneye Technology is a company based in Tel-Aviv, Israel, founded in 2017, that focuses on precision agriculture through the use of artificial intelligence. The company has developed a proprietary selective spraying system that transforms conventional sprayers into smart machines capable of detecting weeds and applying herbicides precisely and in real-time. This innovative approach significantly reduces herbicide usage by as much as 90%, moving away from the traditional method of indiscriminate spraying. Greeneye's technology leverages machine learning and computer vision to automate field scouting and optimize herbicide application, providing farmers with valuable insights into their fields. The multidisciplinary team at Greeneye combines expertise in various fields, including agronomy and mechanical engineering, to deliver sustainable solutions that enhance agricultural practices globally.

MediWound Ltd. is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of innovative therapeutic products aimed at addressing unmet medical needs, particularly in the areas of severe burns and chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, it markets NexoBrid, a biopharmaceutical agent designed for the removal of eschar, or dead tissue, in patients with severe burns. NexoBrid has completed clinical development and is approved for use in Europe. The company is also advancing other products in its pipeline, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic wounds, and MWPC003 for connective tissue disorders. MediWound aims to improve patient outcomes and reduce the complications associated with traditional surgical interventions in wound management.

TriEye Ltd. is a Tel Aviv-based company specializing in Short Wave Infrared (SWIR) sensing technology for autonomous vehicles. Founded in 2017, TriEye has developed the first CMOS-based SWIR imaging systems, enabling high-definition imaging and precise 3D sensing in various weather and lighting conditions, including darkness, rain, fog, and dust. Their innovative technology addresses the challenges of low visibility, providing reliable image data that enhances safety and reduces the risk of accidents. TriEye's solutions are designed to be cost-effective, significantly lowering costs compared to existing industry alternatives, while improving the visual capabilities necessary for the safe operation of autonomous vehicles.

Biond Biologics Ltd is a clinical-stage biopharmaceutical company based in Misgav, Israel, specializing in drug discovery and development for cancer immunotherapy and autoimmune diseases. Founded in 2016, the company focuses on creating innovative therapies that address unmet medical needs. Biond is dedicated to uncovering immunoregulatory pathways and conducting internal research on immune checkpoints and immune-evasion mechanisms. Its novel platform aims to enable antibody-targeting of intracellular immune factors, facilitating the development of immuno-oncology drugs and treatments for autoimmune disorders. Through its commitment to high-quality science and innovative approaches, Biond Biologics seeks to provide breakthrough therapies that can effectively combat critical health conditions.

Aviv Scientific is a leader in the longevity field, focusing on age-related cognitive and functional decline and novel applications of hyperbaric oxygen therapy (HBOT) to maximize human performance. Based on an exclusive partnership with the world’s largest hyperbaric medicine research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv Scientific is introducing a global network of clinics delivering the most effective intervention available today for treating the aging process – The Aviv Medical Program. The three-month regimen has been proven to improve cognitive and physical performance in aging adults. For the first time, in depth comprehensive OMICS data detailing the aging process in healthy adults will be captured, expediting the development of therapeutics and approaches to notably extend healthspan, and ultimately lifespan, in humans.

Ramon.Space specializes in providing computing infrastructure for space applications by equipping satellites with resilient computers designed to withstand the harsh conditions of space. The company's innovative systems feature advanced storage, computing, and connectivity capabilities, enabling real-time data processing and insights. Their software-defined, low-power platform allows for flexibility and supports in-orbit software updates, ensuring that missions can adapt to changing needs. With a focus on small satellites and deep space exploration, Ramon.Space aims to facilitate the next generation of space applications, allowing clients to deploy solutions more quickly and efficiently while minimizing costs.

Rapid Medical Ltd. specializes in developing neurovascular interventional medical devices aimed at enhancing endovascular treatments, particularly for ischemic and hemorrhagic stroke. Founded in 2008 and based in Yokne'am Illit, Israel, the company offers innovative products such as the Tigertriever, a revascularization device; DRIVEWIRE, a guidewire designed for complex anatomical navigation; and Comaneci, a controllable device for managing aneurysm necks. Rapid Medical's mission focuses on creating safe, effective, and user-friendly medical devices that fulfill physicians' needs while improving patient care. The company has established a distribution network across multiple countries in Europe and Asia, ensuring broad access to its products.

Ramon.Space specializes in providing computing infrastructure for space applications by equipping satellites with resilient computers designed to withstand the harsh conditions of space. The company's innovative systems feature advanced storage, computing, and connectivity capabilities, enabling real-time data processing and insights. Their software-defined, low-power platform allows for flexibility and supports in-orbit software updates, ensuring that missions can adapt to changing needs. With a focus on small satellites and deep space exploration, Ramon.Space aims to facilitate the next generation of space applications, allowing clients to deploy solutions more quickly and efficiently while minimizing costs.